Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine

Heart. 1997 Mar;77(3):268-72. doi: 10.1136/hrt.77.3.268.

Abstract

Objective: To evaluate the efficacy of head up tilt guided treatment with metoprolol and clonidine in preventing the recurrence of syncope in patients with malignant vasovagal syncope.

Patients: 20 patients (9 men and 11 women, mean age 33 (SD 17), range 14 to 62 years) with severe symptoms.

Design: Randomised double blind crossover trial; efficacy was assessed by head up tilt testing.

Results: Metoprolol was more effective than clonidine in abolishing syncope (19/20 v 1/20, P < 0.001) but clonidine showed some beneficial effects on time to syncope and severity of hypotension in 12 patients. During an average follow up of 15 (3) months there was a significant reduction in the recurrence of symptoms compared with the previous year in patients who had tilt up guided treatment (18 metoprolol, 1 clonidine).

Conclusions: Treatment guided by head up tilting is a reliable method of treating patients with malignant vasovagal syndrome. Metoprolol was an effective long term treatment for preventing syncope. High doses were more effective and a careful dose titration period helped to minimise withdrawal symptoms and side effects.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adrenergic alpha-Agonists / therapeutic use*
  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Clonidine / therapeutic use*
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metoprolol / therapeutic use*
  • Middle Aged
  • Single-Blind Method
  • Syncope, Vasovagal / diagnosis
  • Syncope, Vasovagal / prevention & control*
  • Tilt-Table Test

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Antagonists
  • Metoprolol
  • Clonidine